Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Michael H. Davidson

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Davidson, Michael H.

Item TypeName
Concept Proprotein Convertases
Academic Article Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
Academic Article Emerging low-density lipoprotein therapies: Targeting PCSK9 for low-density lipoprotein reduction.
Academic Article Diagnosis and treatment of familial hypercholesterolaemia.
Academic Article Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution.
Academic Article AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Academic Article The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.
Academic Article Can We Cure Atherosclerosis?
Academic Article Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
Academic Article PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
Academic Article Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
Academic Article Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.

Search Criteria
  • Proprotein Convertases